Literature DB >> 16049571

Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test.

Michel Bourin1, Fabienne Masse, Martine Hascoët.   

Abstract

BACKGROUND: The antiepileptic drug lamotrigine is effective in the treatment of focal epilepsies. It is thought to act by inhibition of glutamate release through blockade of voltage-sensitive sodium channels and stabilization of the neuronal membrane. Lamotrigine is also effective in the treatment of mood disorders such as bipolar disorder. However, its exact mechanism of action in these conditions remains unclear. The aim of the present study was to evaluate the antidepressant-like effect of lamotrigine in a mouse model of depression, namely the forced swimming test (FST). Association studies using specific and nonspecific ligands acting on serotonin (5-hydroxytryptamine; 5-HT1) receptor subtypes were undertaken to evaluate the potential role of these receptors in the anti-immobility effect of lamotrigine.
METHODS: The mouse FST was performed after single administration of lamotrigine. Subactive doses of lamotrigine were administered in association with subactive doses of the following 5-HT1 receptor agonists or antagonists: 8-hydroxy-2-(di-n-propilamino)-tetralin (8-OH-DPAT, a standard 5-HT(1A) receptor selective agonist), pindolol (a presynaptic and postsynaptic 5-HT(1A/1B) receptor antagonist), NAN-190 (a 5-HT(1A) receptor antagonist), RU 24969 (a 5-HT(1A/1B) receptor agonist) and anpirtoline (5-HT(1B) agonist).
RESULTS: Lamotrigine impaired spontaneous locomotor activity at doses of 4 mg/kg or greater, and activity decreased by more than 50% at the 16 mg/kg dose. When administered alone, lamotrigine (8 and 16 mg/kg) decreased immobility time in the FST. Only 8-OH-DPAT (1 mg/kg), pindolol (32 mg/kg) and RU 24969 (0.5 mg/kg) enhanced the antidepressant-like effect of lamotrigine in the FST.
CONCLUSIONS: These results suggest that postsynaptic 5-HT(1A) receptors might be involved in the activity of lamotrigine. Furthermore, they demonstrate that lamotrigine more closely resembles valproate and carbamazepine than lithium, with the advantage of an anti-immobility effect in the mouse FST when administered on its own.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049571      PMCID: PMC1160563     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  50 in total

Review 1.  Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

Authors:  F Artigas; L Romero; C de Montigny; P Blier
Journal:  Trends Neurosci       Date:  1996-09       Impact factor: 13.837

2.  Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.

Authors:  J P Redrobe; M Bourin
Journal:  Eur J Pharmacol       Date:  1997-05-01       Impact factor: 4.432

3.  The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test.

Authors:  J P Redrobe; C P MacSweeney; M Bourin
Journal:  Eur J Pharmacol       Date:  1996-12-30       Impact factor: 4.432

4.  Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test.

Authors:  M Bourin; J P Redrobe; G B Baker
Journal:  Psychopharmacology (Berl)       Date:  1998-04       Impact factor: 4.530

5.  Effects of lamotrigine on the 5-HT1A receptor function in healthy human males.

Authors:  I S Shiah; L N Yatham; R W Lam; A P Zis
Journal:  J Affect Disord       Date:  1998-05       Impact factor: 4.839

6.  Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder.

Authors:  J Walden; B Hesslinger; D van Calker; M Berger
Journal:  Pharmacopsychiatry       Date:  1996-09       Impact factor: 5.788

7.  Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.

Authors:  F Artigas; V Perez; E Alvarez
Journal:  Arch Gen Psychiatry       Date:  1994-03

8.  A calcium antagonistic effect of the new antiepileptic drug lamotrigine.

Authors:  J von Wegerer; B Hesslinger; M Berger; J Walden
Journal:  Eur Neuropsychopharmacol       Date:  1997-05       Impact factor: 4.600

9.  Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

Authors:  P Blier; R Bergeron
Journal:  J Clin Psychopharmacol       Date:  1995-06       Impact factor: 3.153

10.  Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system.

Authors:  M K Nixon; M Hascoet; M Bourin; M C Colombel
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

View more
  14 in total

1.  Case files of the University of California San Francisco Medical Toxicology Fellowship: lamotrigine toxicity.

Authors:  Michelle Fleurat; Craig Smollin
Journal:  J Med Toxicol       Date:  2012-03

2.  Antidepressant response to chronic citalopram treatment in eight inbred mouse strains.

Authors:  Jianwei Jiao; Angela M Nitzke; Demetrios G Doukas; Mariel P Seiglie; Stephanie C Dulawa
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

Review 3.  Translational research in bipolar disorder: emerging insights from genetically based models.

Authors:  G Chen; I D Henter; H K Manji
Journal:  Mol Psychiatry       Date:  2010-02-09       Impact factor: 15.992

4.  Factors producing a menopausal depressive-like state in mice following ovariectomy.

Authors:  Naoko Bekku; Hiroyuki Yoshimura; Hiroaki Araki
Journal:  Psychopharmacology (Berl)       Date:  2006-06-21       Impact factor: 4.530

5.  Neurogenesis and Neuroplasticity in Major Depression: Its Therapeutic Implication.

Authors:  Michel Bourin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  The effectiveness of anticonvulsants in psychiatric disorders.

Authors:  Heinz C R Grunze
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

7.  Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.

Authors:  Ibrahim Eren; Mustafa Naziroğlu; Arif Demirdaş
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

8.  Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice.

Authors:  Zhen-Zhen Wang; Wei-Xing Yang; Yi Zhang; Nan Zhao; You-Zhi Zhang; Yan-Qin Liu; Ying Xu; Steven P Wilson; James M O'Donnell; Han-Ting Zhang; Yun-Feng Li
Journal:  Sci Rep       Date:  2015-07-10       Impact factor: 4.379

9.  The role of lamotrigine in the management of bipolar disorder.

Authors:  Felicity Ng; Karen Hallam; Nellie Lucas; Michael Berk
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Novel glutamatergic drugs for the treatment of mood disorders.

Authors:  Kyle Ab Lapidus; Laili Soleimani; James W Murrough
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.